Millipore Sigma Vibrant Logo

219467 Cathepsin V, His•Tag®, Human, Recombinant, NSO Cells

View Products on Sigmaaldrich.com
219467
가격 및 재고 조회

개요

Replacement Information

가격 및 재고여부

카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
219467-10UGCN
재고 정보 검색...
현재 재고 없음
현재 재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service

      Plastic ampoule 10 μg
      가격 검색...
      가격을 검색할 수 없습니다
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      가격 문의 추가 정보
      ()이 할인됨
       
      가격 문의
      Description
      OverviewRecombinant, human procathepsin V (amino acids 18-334) fused at the N-terminus to a CD33 signal sequence (amino acids 1-16) and at the C-terminus to a His•Tag® sequence and expressed in NSO cells. Cat V is predominantly expressed in normal thymus, testis, and corneal epithelium. It is involved in the invariant chain degradation in thymic epithelial cells and its overexpression has been detected in myasthenia gravis. Abnormally wide spread expressions in mammary gland and colon have also been reported in breast and colonrectal carcinomas. Although it shows high amino acid identity with cathepsin L (Cat. No. 219382), these two cathepsins have very different tissue distribution and substrate specificity. As a result of glycosylation, this recombinant enzyme migrates ~40 kDa on SDS-PAGE under either reducing or non-reducing conditions. Requires activation prior to use.
      Catalogue Number219467
      Brand Family Calbiochem®
      SynonymsCathepsin L2, Cathepsin U
      References
      ReferencesTolosa, E., et al. 2003. J. Clin. Invest. 112, 517.
      Turk, V., et al. 2001. EMBO J. 20, 4629.
      Somoza, J.R., et al. 2000. Biochemistry 39, 12543.
      Bromme, D., et al. 1999. Biochemistry 38, 2377.
      Adachi, W., et al. 1998. Invest. Ophthalmol. Vis. Sci. 39, 1789.
      Santamaria, I., et al. 1998. Cancer Res. 58, 1624.
      Product Information
      Unit of DefinitionOne unit is defined as the amount of enzyme that will cleave 1 pmol the fluorescent substrate Z-LR-AMC per min at 25°C, pH 5.5.
      EC number3.4.22.43
      FormFrozen liquid
      FormulationIn 800 mM NaCl, 25 mM sodium acetate, 0.8 M NaCl, pH 5.0.
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥95% by SDS-PAGE
      Specific Activity≥300 units/µg
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      ContaminantsEndotoxins: ≤1.0 EU/µg Cathepsin V
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsTo activate rhCathepsin V, pre-incubate it at 20 µg/ml in 25 mM NaOAc, 100 mM NaCl, 5 mM DTT, pH 5.5 at room temperature. Following initial thaw aliquot and freeze (-70°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      카탈로그 번호 GTIN
      219467-10UGCN 04055977218497

      Documentation

      Cathepsin V, His•Tag®, Human, Recombinant, NSO Cells MSDS

      타이틀

      물질안전보건자료(MSDS) 

      Cathepsin V, His•Tag®, Human, Recombinant, NSO Cells Certificates of Analysis

      TitleLot Number
      219467

      References

      참고문헌 보기
      Tolosa, E., et al. 2003. J. Clin. Invest. 112, 517.
      Turk, V., et al. 2001. EMBO J. 20, 4629.
      Somoza, J.R., et al. 2000. Biochemistry 39, 12543.
      Bromme, D., et al. 1999. Biochemistry 38, 2377.
      Adachi, W., et al. 1998. Invest. Ophthalmol. Vis. Sci. 39, 1789.
      Santamaria, I., et al. 1998. Cancer Res. 58, 1624.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision27-November-2008 RFH
      SynonymsCathepsin L2, Cathepsin U
      DescriptionRecombinant, human procathepsin V (amino acids 18-334) fused at the N-terminus to a CD33 signal sequence (amino acids 1-16) and at the C-terminus to a His•Tag® sequence and expressed in NSO cells. Cat V is predominantly expressed in normal thymus, testis, and corneal epithelium. It is involved in the invariant chain degradation in thymic epithelial cells and its overexpression has been detected in myasthenia gravis. Abnormally wide spread expressions in mammary gland and colon have also been reported in breast and colonrectal carcinomas. Although it shows high amino acid identity with cathepsin L (Cat. No. 219382), these two cathepsins have very different tissue distribution and substrate specificity. As a result of glycosylation, this recombinant enzyme migrates ~40 kDa on SDS-PAGE under either reducing or non-reducing conditions. Requires activation prior to use.
      FormFrozen liquid
      FormulationIn 800 mM NaCl, 25 mM sodium acetate, 0.8 M NaCl, pH 5.0.
      Concentration Label Please refer to vial label for lot-specific concentration
      EC number3.4.22.43
      Purity≥95% by SDS-PAGE
      ContaminantsEndotoxins: ≤1.0 EU/µg Cathepsin V
      Specific activity≥300 units/µg
      Unit definitionOne unit is defined as the amount of enzyme that will cleave 1 pmol the fluorescent substrate Z-LR-AMC per min at 25°C, pH 5.5.
      Storage Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsTo activate rhCathepsin V, pre-incubate it at 20 µg/ml in 25 mM NaOAc, 100 mM NaCl, 5 mM DTT, pH 5.5 at room temperature. Following initial thaw aliquot and freeze (-70°C).
      Toxicity Standard Handling
      ReferencesTolosa, E., et al. 2003. J. Clin. Invest. 112, 517.
      Turk, V., et al. 2001. EMBO J. 20, 4629.
      Somoza, J.R., et al. 2000. Biochemistry 39, 12543.
      Bromme, D., et al. 1999. Biochemistry 38, 2377.
      Adachi, W., et al. 1998. Invest. Ophthalmol. Vis. Sci. 39, 1789.
      Santamaria, I., et al. 1998. Cancer Res. 58, 1624.